Effects of Tumor Homogenate Injections on Catalase Activity
Author Information
Author(s): D. H. Adams
Primary Institution: London Hospital Medical College
Hypothesis
Can multiple injections of tumor homogenates simulate the changes in catalase activity observed in tumor-bearing animals?
Conclusion
Multiple injections of Sarcoma 37 homogenate produced changes in liver catalase levels that resembled but did not match those seen in tumor-bearing mice.
Supporting Evidence
- Multiple injections of Sarcoma 37 homogenate produced a depression in liver catalase level.
- The increase in distribution ratio was independent of dose over the range studied.
- Total catalase activity was still 60 percent of normal compared to about 40 percent or less in tumor-bearing animals.
Takeaway
The study looked at how injecting tumor tissue affects a specific enzyme in mice, and found that it doesn't work the same way as when the mice have actual tumors.
Methodology
Young adult CBA strain mice were injected with tumor homogenates, and liver catalase activity was measured in different fractions.
Limitations
The study may not accurately simulate the tumor environment due to the use of homogenates and the maximum tolerated doses.
Participant Demographics
Young adult mice of the CBA strain.
Want to read the original?
Access the complete publication on the publisher's website